{{Rsnum
|rsid=6810298
|Gene=ROPN1
|Chromosome=3
|position=123976128
|Orientation=plus
|GMAF=0.3825
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ROPN1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 52.4 | 41.3 | 6.3
| HCB | 1.5 | 13.1 | 85.4
| JPT | 0.9 | 17.7 | 81.4
| YRI | 3.5 | 36.4 | 60.1
| ASW | 3.6 | 41.8 | 54.5
| CHB | 1.5 | 13.1 | 85.4
| CHD | 1.9 | 14.8 | 83.3
| GIH | 0.0 | 0.0 | 0.0
| LWK | 1.8 | 31.2 | 67.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 4.5 | 45.8 | 49.7
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19706030
|Title=Validation Study of Genetic Associations with Coronary Artery Disease on Chromosome 3q13-21 and Potential Effect Modification by Smoking
|OA=1
}}

{{PMID|17357071|OA=1
}} Peakwide mapping on chromosome 3q13 identifies the kalirin gene as a novel candidate gene for coronary artery disease.

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}